Cargando…
Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683832/ http://dx.doi.org/10.1016/j.vacune.2022.10.021 |
_version_ | 1784835139448078336 |
---|---|
author | Keikha, Masoud |
author_facet | Keikha, Masoud |
author_sort | Keikha, Masoud |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9683832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96838322022-11-25 Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? Keikha, Masoud Vacunas (English Edition) Letter to the Editor Published by Elsevier España, S.L.U. 2022 2022-11-24 /pmc/articles/PMC9683832/ http://dx.doi.org/10.1016/j.vacune.2022.10.021 Text en © 2022 Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Keikha, Masoud Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
title | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
title_full | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
title_fullStr | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
title_full_unstemmed | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
title_short | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
title_sort | recommendation of a fourth sars-cov-2 vaccine dosage in vulnerable individuals, yes or not? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683832/ http://dx.doi.org/10.1016/j.vacune.2022.10.021 |
work_keys_str_mv | AT keikhamasoud recommendationofafourthsarscov2vaccinedosageinvulnerableindividualsyesornot |